AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

May 11, 2010

Primary Completion Date

October 18, 2016

Study Completion Date

October 18, 2016

Conditions
Plaque-type Psoriasis
Interventions
DRUG

AIN457

AIN457A 150 mg powder for solution

DRUG

Placebo

Placebo to AIN457A 150 mg powder for solution

Trial Locations (57)

201

Novartis Investigative Site, Kopavogur

6017

Novartis Investigative Site, Ålesund

10117

Novartis Investigative Site, Berlin

14623

Novartis Investigative Site, Rochester

20354

Novartis Investigative Site, Hamburg

22911

Novartis Investigative Site, Charlottesville

23538

Novartis Investigative Site, Lübeck

24105

Novartis Investigative Site, Kiel

27262

Novartis Investigative Site, High Point

30078

Novartis Investigative Site, Snellville

30263

Novartis Investigative Site, Newnan

30625

Novartis Investigative Site, Hanover

31400

Novartis Investigative Site, Toulouse

35233

Novartis Investigative Site, Birmingham

37075

Novartis Investigative Site, Göttingen

40291

Novartis Investigative Site, Louisville

47713

Novartis Investigative Site, Evansville

48038

Novartis Investigative Site, Clinton Township

48149

Novartis Investigative Site, Münster

48202

Novartis Investigative Site, Detroit

49100

Novartis Investigative Site, Petah Tikva

53105

Novartis Investigative Site, Bonn

55131

Novartis Investigative Site, Mainz

55455

Novartis Investigative Site, Minneapolis

60590

Novartis Investigative Site, Frankfurt

61820

Novartis Investigative Site, Champaign

62703

Novartis Investigative Site, Springfield

63117

Novartis Investigative Site, St Louis

66606

Novartis Investigative Site, Topeka

68131

Novartis Investigative Site, Omaha

68144

Novartis Investigative Site, Omaha

72076

Novartis Investigative Site, Tübingen

72205

Novartis Investigative Site, Little Rock

75204

Novartis Investigative Site, Dallas

78759

Novartis Investigative Site, Austin

89052

Novartis Investigative Site, Henderson

91054

Novartis Investigative Site, Erlangen

91105

Novartis Investigative Site, Pasadena

92123

Novartis Investigative Site, San Diego

97035

Novartis Investigative Site, Lake Oswego

97210

Novartis Investigative Site, Portland

1834111

Novartis Investigative Site, Afula

5265601

Novartis Investigative Site, Ramat Gan

06202

Novartis Investigative Site, Nice

01307

Novartis Investigative Site, Dresden

467-8602

Novartis Investigative Site, Nagoya

814-0180

Novartis Investigative Site, Fukuoka

807-8556

Novartis Investigative Site, Kitakyushu

830-0011

Novartis Investigative Site, Kurume

371-8511

Novartis Investigative Site, Maebashi

066-0021

Novartis Investigative Site, Chitose

113-8655

Novartis Investigative Site, Bunkyo-ku

173-8610

Novartis Investigative Site, Itabashi-ku

105-8471

Novartis Investigative Site, Minato-ku

141 8625

Novartis Investigative Site, Shinagawa-ku

NO-5021

Novartis Investigative Site, Bergen

0424

Novartis Investigative Site, Oslo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY